Alkermes PLC Form 4 insider transactions

Director Emily Peterson Alva exercised stock options and disposed of shares of Alkermes plc on June 9, 2024.

Director Christopher I. Wright reports acquisition and disposal of Alkermes plc ordinary shares and restricted stock units on June 8, 2024.

Director Christopher I. Wright reports acquisition of Alkermes plc shares through stock options and restricted stock units, as detailed in a recent SEC Form 4 filing.

Director Frank Anders Wilson reports acquisition of stock options and restricted stock units in Alkermes plc, according to a Form 4 filing.

Director Nancy Snyderman reports acquisition of restricted stock units and stock options in Alkermes plc.

Director Brian P. McKeon reports acquisition of restricted stock units and stock options in Alkermes plc.

Director Nancy Lurker reports the acquisition of stock options and restricted stock units in Alkermes plc.

Director Cato T. Laurencin reports acquisition of stock options and restricted stock units in Alkermes plc.

Director Richard Gaynor reports the acquisition of stock options and restricted stock units (RSUs) in Alkermes plc.

Director David Angelo Daglio Jr. reports acquisition of Alkermes plc shares and options, signaling potential confidence in the company's future.

Director Shane Cooke reports acquisition of stock options and restricted stock units in Alkermes plc.

Emily Peterson Alva, a director of Alkermes plc, reports the acquisition of stock options and restricted stock units.

Director Nancy Lurker reports acquisition of stock options and restricted stock units in Alkermes plc.

Christian Todd Nichols, SVP, Chief Commercial Officer of Alkermes plc, sold 10,417 ordinary shares at a weighted average price of $28.1021 on March 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Christian Todd Nichols, SVP and Chief Commercial Officer of Alkermes plc, reports the acquisition and disposal of ordinary shares and derivative securities.

Samuel Joseph Parisi, VP of Finance (Interim PAO) at Alkermes plc, reports acquisition and disposal of ordinary shares and derivative securities.

Iain Michael Brown, CFO of Alkermes plc, reports the acquisition and disposal of ordinary shares and derivative securities.

David Gaffin, EVP, CLO of Alkermes, reports acquisition and disposal of ordinary shares and derivative securities.

Michael Landine, SVP at Alkermes, reports the vesting of restricted stock units and subsequent disposition of shares to cover tax obligations.

Blair C. Jackson, EVP and Chief Operating Officer of Alkermes plc, reports the vesting of restricted stock units and acquisition of new stock options.

EVP of R&D and Chief Medical Officer of Alkermes, Craig C. Hopkinson, reports acquisition and disposal of ordinary shares and derivative securities.

Alkermes CEO Richard Pops reports the acquisition of 274,328 employee stock options in a recent Form 4 filing with the SEC.